Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Infliximab

Central or peripheral demyelination: 2 case reports

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Nozaki K, Judson M.Central and Peripheral Demyelination as a Side Effect of Infliximab: A Case Series. 62nd Annual Meeting of the American Academy of Neurology: abstr. S47.002, 10 Apr 2010. Available from: URL: http://www.abstracts2view.com/aan - USA

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Infliximab. React. Wkly. 1300, 28 (2010). https://doi.org/10.2165/00128415-201013000-00091

    Download citation

    Keywords

    • Neuropathy
    • White Matter
    • Infliximab
    • Sarcoidosis
    • Plasma Exchange